Definitive Healthcare Corp. (DH)
Market Cap | 823.35M |
Revenue (ttm) | 251.42M |
Net Income (ttm) | -202.39M |
Shares Out | 117.79M |
EPS (ttm) | -1.79 |
PE Ratio | n/a |
Forward PE | 17.83 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 417,618 |
Open | 6.77 |
Previous Close | 6.73 |
Day's Range | 6.74 - 6.99 |
52-Week Range | 5.53 - 12.46 |
Beta | 1.39 |
Analysts | Hold |
Price Target | 10.94 (+56.51%) |
Earnings Date | May 7, 2024 |
About DH
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician... [Read more]
Financial Performance
In 2023, DH's revenue was $251.42 million, an increase of 12.92% compared to the previous year's $222.65 million. Losses were -$202.39 million, 2702.4% more than in 2022.
Financial StatementsAnalyst Forecast
According to 9 analysts, the average rating for DH stock is "Hold." The 12-month stock price forecast is $10.94, which is an increase of 56.51% from the latest price.
News
Definitive Healthcare Announces Timing of Its First Quarter 2024 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that...
VML and Definitive Healthcare announce partnership to transform key opinion leader management
Partnership offers solution to streamline engagement between pharmaceutical companies and KOLs to help increase the value of the clinical collaborations and conversations Partnership offers solution t...
Definitive Healthcare earns 2024 Middle Market Leader Award from Boston Business Journal
FRAMINGHAM, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it has been named one of the...
Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2023
Fourth quarter revenue grew 9% year-over-year to $65.9 million Full year 2023 revenue grew 13% year-over-year to $251.4 million FRAMINGHAM, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Definitive Healthc...
Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that ...
Definitive Healthcare Announces CEO Transition
Jason Krantz, Founder and Executive Chairman, to Serve as Interim CEO Company Reaffirms Fourth Quarter 2023 Guidance and Issues Preliminary Guidance for 2024 FRAMINGHAM, Mass., Jan. 16, 2024 (GLOBE NE...
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
FRAMINGHAM, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of...
Definitive Healthcare Announces Timing of Its Third Quarter 2023 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that ...
Definitive Healthcare Names Carrie Lazorchak as Chief Revenue Officer
FRAMINGHAM, Mass., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that Carrie Lazorchak has been ...
Definitive Healthcare Welcomes Scott Stephenson to Board of Directors
FRAMINGHAM, Mass., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced two changes to its Board of Di...
Definitive Healthcare Corp. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FRAMINGHAM, Mass., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with Definitive H...
Definitive Healthcare to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
FRAMINGHAM, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Definitive Healthcare Corp. - DH
NEW YORK , Aug. 18, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Definitive Healthcare Corp. ("Definitive Healthcare" or the "Company") (NASDAQ: DH). Such inves...
Definitive Healthcare acquires Populi
Acquisition broadens Definitive Healthcare's suite of healthcare commercial intelligence solutions with new data, analytics, and visualization tools tailor-built for the provider market Acquisition br...
Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2023
FRAMINGHAM, Mass., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, toda...
Definitive Healthcare Reports Preliminary Financial Results for Second Quarter Fiscal Year 2023, Reaffirms Full Year Guidance for Revenue and Adjusted EBITDA, and Announces Restatement of Previously Issued Financials
FRAMINGHAM, Mass. , Aug. 01, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, tod...
Definitive Healthcare Announces Timing of Its Second Quarter 2023 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., July 13, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that ...
Definitive Healthcare expands the Atlas Dataset
New enhancements include a 5% increase in all-payor medical claims data, new intelligence on behavioral health, and a 50% increase in healthcare executive data New enhancements include a 5% increase i...
Definitive Healthcare to Present at the Stifel 2023 Cross Sector Insight Conference and the 43rd Annual William Blair Growth Stock Conference
FRAMINGHAM, Mass., May 31, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that i...
Definitive Healthcare publishes 2022 Sustainability Report
First annual report highlights Definitive Healthcare's successful efforts related to culture, governance, and the environment First annual report highlights Definitive Healthcare's successful efforts ...
Definitive Healthcare to Present at the 51st Annual J.P. Morgan Global Technology, Media and Communications Conference
FRAMINGHAM, Mass., May 15, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that i...
Definitive Healthcare Announces Timing of Its First Quarter 2023 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., April 24, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that...
Definitive Healthcare brings healthcare commercial intelligence to Snowflake Marketplace
Joint customers can integrate data from Definitive Healthcare's Atlas Dataset in the Snowflake Data Cloud Joint customers can integrate data from Definitive Healthcare's Atlas Dataset in the Snowflake...
Definitive Healthcare to Present at the Raymond James 2023 Institutional Investors Conference
FRAMINGHAM, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that ...
Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2022
Fourth quarter revenue grew 31% year-over-year to $60.6 million Full year 2022 revenue grew 34% to $222.7 million